Black Triangle Scheme (▼)

"Only when large numbers of patients have taken a medicine are rare or long latency adverse effects identified. Therefore, effective surveillance after marketing is essential for the identification of rare adverse effects, and to ensure that appropriate action is taken.

The Commission on Human Medicines (CHM) and the MHRA encourages the reporting of all suspected reactions to newer drugs and vaccines, which are denoted by an inverted Black Triangle symbol (▼)."

- gov.uk

Report all suspected adverse drug reactions to these products through the Yellow Card Scheme.

To see which vaccines are under Black Triangle Sheme, visit our Package Insert, Vaccine Analysis Print and Black Triangle pages.